Atara BiotherapeuticsATRA 13F holders, Q2 2024 (June 30) 44 holders
4 famous investors
$8.50 avg. 13F price*
At the end of Q2 2024 , 44 institutions reported holding Atara Biotherapeutics Inc. (ATRA) in their 13F filings. The largest holders were Redmile Group, LLC ($3.8M), EcoR1 Capital, LLC ($3.5M) and Citadel Advisors ($2.2M). 4 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
Company Atara Biotherapeutics Inc.
CUSIP 046513206
Latest filing quarter Q2 2026 History Number of 13F holders
Total Exit/New Position Q2 2024 Institutions Total Value New Positions 44 $22.5M Exits 0 $0
Ownership 44 holders Portfolio Manager % of Holder's Portfolio Change Shares Value ▼ Redmile Group, LLC 0.23% New 452,270 $3.8M EcoR1 Capital, LLC 0.11% New 406,679 $3.5M Citadel Advisors 0.00% New 260,480 $2.2M Bank of America Corp. 0.00% New 186,011 $1.6M Vanguard Group Inc. 0.00% New 169,336 $1.4M Centiva Capital, LP 0.06% New 140,250 $1.2M Acadian Asset Management LLC 0.00% New 119,370 $1.0M Millennium Management 0.00% New 116,671 $992K Vestal Point Capital, LP 0.07% New 112,000 $952K Qube Research & Technologies Ltd 0.00% New 102,663 $873K Tang Capital Management LLC 0.07% New 75,196 $639K Woodline Partners LP 0.01% New 70,889 $603K BlackRock Inc. 0.00% New 61,145 $520K Renaissance Technologies 0.00% New 46,064 $392K Geode Capital Management, LLC 0.00% New 42,677 $363K Staley Capital Advisers Inc. 0.02% New 40,000 $340K BNP Paribas Financial Markets 0.00% New 36,724 $312K Prudential Financial Inc. 0.00% New 36,340 $309K Northern Trust Corp. 0.00% New 31,492 $268K Charles Schwab Investment Management Inc. 0.00% New 26,155 $222K FMR LLC 0.00% New 17,680 $150K AQR Capital Management 0.00% New 15,079 $128K State Street Corp. 0.00% New 14,673 $125K Susquehanna International Group, LLP 0.00% New 14,455 $123K Bridgeway Capital Management, LLC 0.00% New 14,000 $119K Morgan Stanley 0.00% New 9,785 $83K Cubist Systematic Strategies, LLC 0.00% New 9,271 $79K Point72 Asia (Singapore) Pte. Ltd. 0.01% New 6,292 $53K Group One Trading LLC 0.00% New 4,789 $41K Tower Research Capital LLC (TRC) 0.00% New 4,467 $38K Citigroup Inc. 0.00% New 3,172 $27K Royal Bank of Canada 0.00% New 2,045 $17K MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.00% — 1,927 $16K JPMorgan Chase & Co. 0.00% New 1,660 $14K Rhumbline Advisers 0.00% New 682 $6K UBS Group AG 0.00% New 403 $3K Wells Fargo & Company 0.00% New 315 $3K Lazard Asset Management LLC 0.00% New 308 $2K Macquarie Group Ltd. 0.00% New 197 $2K IFP Advisors, Inc 0.00% New 180 $2K Catalyst Funds Management Pty Ltd 0.00% New 100 $850 Federated Hermes, Inc. 0.00% New 57 $485 New York State Common Retirement Fund 0.00% New 32 $272 Russell Investments Group, Ltd. 0.00% New 2 $17
"% of holder's portfolio" is ATRA's weight in each manager's 13F, not the share of Atara Biotherapeutics Inc. the manager owns.